Published in Am J Physiol on October 01, 1991
Regulation of tissue injury responses by the exposure of matricryptic sites within extracellular matrix molecules. Am J Pathol (2000) 2.21
Neither fibrin nor plasminogen activator inhibitor-1 deficiency protects lung function in a mouse model of acute lung injury. Am J Physiol Lung Cell Mol Physiol (2008) 1.62
Mechanisms of fibrinogen-induced microvascular dysfunction during cardiovascular disease. Acta Physiol (Oxf) (2009) 1.18
Effect of free and vesicle-bound cysteine proteinases of Porphyromonas gingivalis on plasma clot formation: implications for bleeding tendency at periodontitis sites. Infect Immun (1995) 1.13
Endothelial contractile cytoskeleton and microvascular permeability. Cell Health Cytoskelet (2009) 1.01
Fibulin-1 and fibrinogen in human atherosclerotic lesions. Histochem Cell Biol (2009) 0.91
Fibrinogen-gamma C-terminal fragments induce endothelial barrier dysfunction and microvascular leak via integrin-mediated and RhoA-dependent mechanism. Arterioscler Thromb Vasc Biol (2009) 0.83
Fibrinogen degradation product fragment D induces endothelial cell detachment by activation of cell-mediated fibrinolysis. J Clin Invest (1992) 0.82
Proangiogenic microtemplated fibrin scaffolds containing aprotinin promote improved wound healing responses. Angiogenesis (2013) 0.79
Fibrinogen up-regulates the expression of monocyte chemoattractant protein 1 in human saphenous vein endothelial cells. Biochem J (1999) 0.77
Validating recommendations for coronary angiography following acute myocardial infarction in the elderly: a matched analysis using propensity scores. J Clin Epidemiol (2001) 7.46
Generalized pustular psoriasis. A clinical and epidemiological study of 104 cases. Br J Dermatol (1968) 4.42
1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). J Am Coll Cardiol (1999) 4.15
ACC/AHA Guidelines for Exercise Testing. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Exercise Testing). J Am Coll Cardiol (1997) 3.14
Electrical method for detection of endothelial cell shape change in real time: assessment of endothelial barrier function. Proc Natl Acad Sci U S A (1992) 3.00
Appropriateness of coronary angiography after myocardial infarction among Medicare beneficiaries. Managed care versus fee for service. N Engl J Med (2000) 2.75
The effect of atherosclerosis on the vasomotor response of coronary arteries to mental stress. N Engl J Med (1991) 2.74
Relation between operator and hospital volume and outcomes following percutaneous coronary interventions in the era of the coronary stent. JAMA (2000) 2.59
ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Chronic Stable Angina). J Am Coll Cardiol (1999) 2.58
Integrated management of filarial lymphedema for rural communities. Lymphology (2007) 2.54
Right ventricular infarction. N Engl J Med (1994) 2.48
Regulation of vascular endothelial barrier function. Am J Physiol (1994) 2.40
Predictors of mortality for patients undergoing cardiac valve replacements in New York State. Ann Thorac Surg (2000) 2.39
The quality of life in acne: a comparison with general medical conditions using generic questionnaires. Br J Dermatol (1999) 2.37
ACC/AHA guidelines for implantation of cardiac pacemakers and antiarrhythmia devices: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Pacemaker Implantation). J Am Coll Cardiol (1998) 2.27
Clinical and angiographic predictors of operative mortality from the collaborative study in coronary artery surgery (CASS). Circulation (1981) 2.27
The prognosis of generalized pustular psoriasis. Br J Dermatol (1971) 2.15
Coronary angioplasty volume-outcome relationships for hospitals and cardiologists. JAMA (1997) 2.11
Thrombin-induced increase in albumin permeability across the endothelium. J Cell Physiol (1986) 2.04
Endothelial cell-surface gp60 activates vesicle formation and trafficking via G(i)-coupled Src kinase signaling pathway. J Cell Biol (2000) 2.02
Inhibition of NF-kappaB activation by pyrrolidine dithiocarbamate prevents In vivo expression of proinflammatory genes. Circulation (1999) 1.98
Gp60 activation mediates albumin transcytosis in endothelial cells by tyrosine kinase-dependent pathway. J Biol Chem (1997) 1.96
Prognostic importance of a clinical profile and exercise test in medically treated patients with coronary artery disease. J Am Coll Cardiol (1984) 1.91
ACC/AHA guidelines for exercise testing: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Exercise Testing). Circulation (1997) 1.83
Coronary arteriography and coronary artery bypass surgery: morbidity and mortality in patients ages 65 years or older. A report from the Coronary Artery Surgery Study. Circulation (1983) 1.83
Protein kinase C-alpha signals rho-guanine nucleotide dissociation inhibitor phosphorylation and rho activation and regulates the endothelial cell barrier function. J Biol Chem (2001) 1.82
Exercise stress testing. Correlations among history of angina, ST-segment response and prevalence of coronary-artery disease in the Coronary Artery Surgery Study (CASS). N Engl J Med (1979) 1.79
Survival of medically treated patients in the coronary artery surgery study (CASS) registry. Circulation (1982) 1.79
Mechanisms regulating endothelial cell barrier function. Am J Physiol Lung Cell Mol Physiol (2000) 1.77
Percutaneous laser thermal angioplasty: initial clinical results with a laser probe in total peripheral artery occlusions. Lancet (1986) 1.72
Prognostic value of angiographic indices of coronary artery disease from the Coronary Artery Surgery Study (CASS). J Clin Invest (1983) 1.70
Activation of protein kinase C pathway contributes to hydrogen peroxide-induced increase in endothelial permeability. Lab Invest (1992) 1.66
Prognostic significance of angiographically documented left ventricular aneurysm from the Coronary Artery Surgery Study (CASS). Am J Cardiol (1982) 1.65
Transcriptional mechanisms of acute lung injury. Am J Physiol Lung Cell Mol Physiol (2001) 1.63
Larva therapy in wound management. J R Soc Med (2000) 1.59
Thrombin-induced expression of endothelial P-selectin and intercellular adhesion molecule-1: a mechanism for stabilizing neutrophil adhesion. J Cell Biol (1992) 1.59
Prevention of coronary artery disease. A medical imperative. N Engl J Med (1990) 1.58
Vesiculo-bullous Darier's disease. Br J Dermatol (1990) 1.52
Inferior myocardial infarction. High-risk subgroups. Circulation (1990) 1.52
Reference sample method for cardiac output and regional blood flow determinations in the rat. J Appl Physiol (1976) 1.52
The relationship between operator volume and outcomes after percutaneous coronary interventions in high volume hospitals in 1994-1996: the northern New England experience. Northern New England Cardiovascular Disease Study Group. J Am Coll Cardiol (1999) 1.50
Thrombin-induced p65 homodimer binding to downstream NF-kappa B site of the promoter mediates endothelial ICAM-1 expression and neutrophil adhesion. J Immunol (1999) 1.50
Ca(2+) signalling and PKCalpha activate increased endothelial permeability by disassembly of VE-cadherin junctions. J Physiol (2001) 1.49
In vivo inhibition of nuclear factor-kappa B activation prevents inducible nitric oxide synthase expression and systemic hypotension in a rat model of septic shock. J Immunol (1997) 1.47
Donor attitudes about exporting and importing blood. Transfusion (1997) 1.43
Abnormal endothelium-dependent coronary vasomotion in hypertensive patients. J Am Coll Cardiol (1992) 1.43
Diagnos and management of massive pulmonary embolism. Surg Clin North Am (1968) 1.42
Evidence-based humanitarian relief interventions. Lancet (1995) 1.41
Mechanisms of increased endothelial permeability. Can J Physiol Pharmacol (1996) 1.40
Increased endothelial albumin permeability mediated by protein kinase C activation. J Clin Invest (1990) 1.39
THE USE OF THE RUSSELL APPARATUS IN THE TREATMENT OF FRACTURES OF THE SHAFT OF THE FEMUR. Ann Surg (1927) 1.38
Comparison of coronary artery bypass surgery and medical therapy in patients 65 years of age or older. A nonrandomized study from the Coronary Artery Surgery Study (CASS) registry. N Engl J Med (1985) 1.36
Chromosomal abnormalities produced by folic acid antagonists. Br J Dermatol (1965) 1.36
Endothelial monolayer permeability to macromolecules. Fed Proc (1987) 1.36
Effects of 10% formalin fixation on fixed lung volume and lung tissue shrinkage. A comparison of eleven laboratory species. Am Rev Respir Dis (1985) 1.35
Acute regional circulatory and renal hemodynamic effects of converting-enzyme inhibition in patients with congestive heart failure. Circulation (1981) 1.35
Abrogation of thrombin-induced increase in pulmonary microvascular permeability in PAR-1 knockout mice. Physiol Genomics (2000) 1.34
6-Hydroxydopamine-induced alterations in blood-brain barrier permeability. Eur J Neurosci (2005) 1.33
Albumin uptake and transcytosis in endothelial cells in vivo induced by albumin-binding protein. Am J Physiol Lung Cell Mol Physiol (2001) 1.32
Guidelines for perioperative cardiovascular evaluation for noncardiac surgery. Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). J Am Coll Cardiol (1996) 1.31
Molecular sieving characteristics of the cultured endothelial monolayer. J Cell Physiol (1987) 1.31
Psychological correlates of coronary angiographic findings. Arch Intern Med (1976) 1.31
Differences in compensatory vessel enlargement, not intimal formation, account for restenosis after angioplasty in the hypercholesterolemic rabbit model. Circulation (1994) 1.31
Measurement of albumin permeability across endothelial monolayers in vitro. J Appl Physiol (1985) (1987) 1.30
Angiotensin converting enzyme inhibition in patients with congestive heart failure. Circulation (1978) 1.30
Use of ESAT-6 in the interferon-gamma test for diagnosis of bovine tuberculosis following skin testing. Vet Microbiol (2001) 1.28
Thrombin-induced chemotaxis and aggregation of neutrophils. J Cell Physiol (1986) 1.28
Recombinant tumor necrosis factor increases pulmonary vascular permeability independent of neutrophils. Proc Natl Acad Sci U S A (1988) 1.27
Protein kinase C-delta regulates thrombin-induced ICAM-1 gene expression in endothelial cells via activation of p38 mitogen-activated protein kinase. Mol Cell Biol (2001) 1.27
Tumor necrosis factor mediates experimental pulmonary edema by ICAM-1 and CD18-dependent mechanisms. J Clin Invest (1992) 1.26
Transport across the endothelium: regulation of endothelial permeability. Handb Exp Pharmacol (2006) 1.26
Incidence and prognostic implications of heart block complicating inferior myocardial infarction treated with thrombolytic therapy: results from TIMI II. J Am Coll Cardiol (1992) 1.26
Multivariate discriminant analysis of the clinical and angiographic predictors of operative mortality from the Collaborative Study in Coronary Artery Surgery (CASS). J Thorac Cardiovasc Surg (1980) 1.26
Medical versus early surgical therapy in patients with triple-vessel disease and mild angina pectoris: a CASS registry study of survival. Ann Thorac Surg (1987) 1.24
Lymphatics of the skin. Neglected but important. Int J Dermatol (1986) 1.24
Impact of underuse, overuse, and discretionary use on geographic variation in the use of coronary angiography after acute myocardial infarction. Med Care (2001) 1.23
Comparison of the clinical profile and outcome of women and men in cardiac rehabilitation. Am J Cardiol (1992) 1.22
E-selectin expression in human endothelial cells by TNF-alpha-induced oxidant generation and NF-kappaB activation. Am J Physiol (1998) 1.20
Activation of NF-kappaB induced by H(2)O(2) and TNF-alpha and its effects on ICAM-1 expression in endothelial cells. Am J Physiol Lung Cell Mol Physiol (2000) 1.19
Angiotensin inhibition in severe heart failure: acute central and limb hemodynamic effects of captopril with observations on sustained oral therapy. Am Heart J (1981) 1.19
International comparisons of waiting times for cardiovascular procedures: a commentary on the long queue. J Am Coll Cardiol (1995) 1.18
Tumor necrosis factor-alpha-mediated decrease in glutathione increases the sensitivity of pulmonary vascular endothelial cells to H2O2. J Clin Invest (1992) 1.18
A model of bovine tuberculosis control in domesticated cattle herds. Proc Biol Sci (1997) 1.18
Delayed pressure urticaria. Br J Dermatol (1968) 1.16
Effect of granulocytopenia on extravascular lung water content after microembolization. Am Rev Respir Dis (1980) 1.16
Hydrogen peroxide-induced increase in endothelial adhesiveness is dependent on ICAM-1 activation. Am J Physiol (1993) 1.16
H2O2 and tumor necrosis factor-alpha activate intercellular adhesion molecule 1 (ICAM-1) gene transcription through distinct cis-regulatory elements within the ICAM-1 promoter. J Biol Chem (1995) 1.15
Use of mycobacterial peptides and recombinant proteins for the diagnosis of bovine tuberculosis in skin test-positive cattle. Vet Rec (2003) 1.15
Herniation of mitral leaflets in the Ehlers-Danlos syndrome. Am J Cardiol (1975) 1.14
Acute and long-term effects of enalapril on the cardiovascular response to exercise and exercise tolerance in patients with congestive heart failure. J Am Coll Cardiol (1985) 1.14